Scientists developed a bifunctional therapeutic strategy by transforming living tumor cells into a therapeutic, using the gene editing tool CRISPR-Cas9 and repurposing them to release tumor cell killing agent. In addition, the engineered tumor cells were designed to...
An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to significant tumor regression in mice, report investigators from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National...
